SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Auberton-Herve Andre-Jacques – ‘4’ for 6/9/23 re: Bionik Laboratories Corp.

On:  Wednesday, 6/21/23, at 10:55am ET   ·   For:  6/9/23   ·   As:  Director   ·   Accession #:  1104659-23-73228   ·   File #:  0-54717

Previous ‘4’:  ‘4’ on 6/21/22 for 7/15/21   ·   Next:  ‘4’ on 6/21/23 for 6/13/23   ·   Latest:  ‘4’ on 12/26/23 for 12/21/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 6/21/23  Auberton-Herve Andre-Jacques      4          Director    1:5K   Bionik Laboratories Corp.         Toppan Merrill/FA

Statement of Changes in Beneficial Ownership of Securities by an Insider   —   Form 4   —   SEA’34

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 4           Ownership Document -- tm2319148-5_4seq1.xml/4.7     HTML      6K 




        

This ‘4’ Document is an XML Data File that may be rendered in various formats:

  Form 4    –   Plain Text   –  SEC Website  –  EDGAR System  –    XML Data    –  <?xml?> File
 

 
XML Data rendering:  Ownership Document — tm2319148-5_4seq1.xml/4.7
 
                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<ownershipDocument>
<schemaVersion> X0407 </schemaVersion>
<documentType> 4 </documentType>
<periodOfReport> 2023-06-09 </periodOfReport>
<notSubjectToSection16> 0 </notSubjectToSection16>
<issuer>
<issuerCik> 0001508381 </issuerCik>
<issuerName> Bionik Laboratories Corp. </issuerName>
<issuerTradingSymbol> BNKL </issuerTradingSymbol>
</issuer>
<reportingOwner>
<reportingOwnerId>
<rptOwnerCik> 0001730329 </rptOwnerCik>
<rptOwnerName> AUBERTON-HERVE ANDRE-JACQUES </rptOwnerName>
</reportingOwnerId>
<reportingOwnerAddress>
<rptOwnerStreet1> C/O BIONIK LABORATORIES CORP. </rptOwnerStreet1>
<rptOwnerStreet2> 80 COOLIDGE HILL ROAD </rptOwnerStreet2>
<rptOwnerCity> WATERTOWN </rptOwnerCity>
<rptOwnerState> MA </rptOwnerState>
<rptOwnerZipCode> 02472 </rptOwnerZipCode>
<rptOwnerStateDescription></rptOwnerStateDescription>
</reportingOwnerAddress>
<reportingOwnerRelationship>
<isDirector> 1 </isDirector>
<isOfficer> 0 </isOfficer>
<isTenPercentOwner> 0 </isTenPercentOwner>
<isOther> 0 </isOther>
<officerTitle></officerTitle>
<otherText></otherText>
</reportingOwnerRelationship>
</reportingOwner>
<aff10b5One> 0 </aff10b5One>
<nonDerivativeTable>
<nonDerivativeTransaction>
<securityTitle>
<value> Common Stock </value>
</securityTitle>
<transactionDate>
<value> 2023-06-09 </value>
</transactionDate>
<deemedExecutionDate></deemedExecutionDate>
<transactionCoding>
<transactionFormType> 4 </transactionFormType>
<transactionCode> P </transactionCode>
<equitySwapInvolved> 0 </equitySwapInvolved>
</transactionCoding>
<transactionTimeliness></transactionTimeliness>
<transactionAmounts>
<transactionShares>
<value> 650000 </value>
</transactionShares>
<transactionPricePerShare>
<value> 0.60 </value>
<footnoteId id="F1"/>
</transactionPricePerShare>
<transactionAcquiredDisposedCode>
<value> A </value>
</transactionAcquiredDisposedCode>
</transactionAmounts>
<postTransactionAmounts>
<sharesOwnedFollowingTransaction>
<value> 923160 </value>
</sharesOwnedFollowingTransaction>
</postTransactionAmounts>
<ownershipNature>
<directOrIndirectOwnership>
<value> I </value>
</directOrIndirectOwnership>
<natureOfOwnership>
<value> Shares held through Star SCI </value>
</natureOfOwnership>
</ownershipNature>
</nonDerivativeTransaction>
<nonDerivativeHolding>
<securityTitle>
<value> Common Stock </value>
</securityTitle>
<postTransactionAmounts>
<sharesOwnedFollowingTransaction>
<value> 10693 </value>
</sharesOwnedFollowingTransaction>
</postTransactionAmounts>
<ownershipNature>
<directOrIndirectOwnership>
<value> I </value>
</directOrIndirectOwnership>
<natureOfOwnership>
<value> Shares held through 4A Consulting and Engineering </value>
</natureOfOwnership>
</ownershipNature>
</nonDerivativeHolding>
<nonDerivativeHolding>
<securityTitle>
<value> Common Stock </value>
</securityTitle>
<postTransactionAmounts>
<sharesOwnedFollowingTransaction>
<value> 95149 </value>
</sharesOwnedFollowingTransaction>
</postTransactionAmounts>
<ownershipNature>
<directOrIndirectOwnership>
<value> D </value>
</directOrIndirectOwnership>
</ownershipNature>
</nonDerivativeHolding>
</nonDerivativeTable>
<footnotes>
<footnote id="F1"> The reporting person acquired the shares of common stock in lieu of cash payment of an aggregate of $390,000 in accrued and unpaid fees relating to reporting person's services as Chairman of the Board of the Issuer. </footnote>
</footnotes>
<ownerSignature>
<signatureName> /s/ Andre-Jacques Auberton-Herve </signatureName>
<signatureDate> 2023-06-20 </signatureDate>
</ownerSignature>
</ownershipDocument>


Top
Filing Submission 0001104659-23-073228   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., May 17, 1:43:09.2pm ET